 OncoSec Medical Incorporated NASDAQ:ONCS the Company or OncoSec, a company developing late-stage intratumoral cancer immunotherapies, today announced that the class action and related books and records litigation brought by Alpha Holdings, Inc. Alpha in Nevada state court have been dismissed, with prejudice. The class action sought to enjoin the closing of a strategic investment and relationship that OncoSec secured from two partners, Grand Decade Developments Limited, and its U.S. affiliate, Sirtex Medical US Holdings, Inc. the CGPSirtex Transaction. Grand Decade Developments Limited is a wholly-owned subsidiary of China Grand Pharmaceutical and Healthcare Holdings Limited. The class action was commenced in late 2019 by Alpha, a South Korea-based institutional investor in OncoSec. 